hims fda warning letter compounded semaglutide 2025 issued 25 letters to telehealth companies for false and misleading claims about GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Hims Semaglutide (2026): FDA Warnings,

Study Selection We selected pharmacokinetic studies of any injectable GLP1RA given with an oral medication, and product prescribing sheets reporting data without access to the original study

Are there still blue oceans and growth opportunities for GLP-1

Force Factor Super GLP-1 Support Soft Chews are formulated to support natural GLP-1 levels, metabolism, and healthy blood sugar.

rare pancreatitis

To help answer these and many others, I recently launched The GLP-1 Dietitian Hub, a growing community and newsletter dedicated to empowering dietitians with practical, up to date resources, relevant research, and a space to connect so we can navigate GLP-1 therapy with confidence

The analysis spanned data from January 1, 2015, to December 31, 2023